McCormick Place Convention Center, Chicago, IL | July 29th August - 1st, 2024

Welcome to the DxPx US 2024 Ticket Shop!

timeline wide of tickets pricing dxpx us 2023 at the aacc

Find the Right DxPx Ticket For You

DxPx Tickets for Startups

DxPx is the number one conference for start ups in the Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools space to meet with investors & peers. All startup tickets include the following –

  • 4 Days of in-person meetings – July 29th – August 1st, 2024
  • Access all exhibition, networking, Startup City areas & panel discussions
  • Partnering Platform to schedule in-person meetings
 
*Qualifications for start up company status includes: less than $1 million in revenue/funding, less than 5 years old and under 30 employees.

Startup Ticket

$999

42plus1
Startup Ticket

$499

Startup City
Booth

dxpx-impressions-35

$ 2,500

Startup Presentation

$ 750

DxPx Tickets for Growth Companies

 

Growth companies in the Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools space come to DxPx to meet with potential investors & learn and network with their peers. All growth company tickets include the following – 

  • 4 Days of in-person meetings – July 29th – August 1st, 2024
  • Access all exhibition, networking, Startup City areas & panel discussions
  • Partnering Platform to schedule in-person meetings

Growth Company Ticket

$ 1,249 999

Growth Company Presentation

$ 750

Investor Networking Dinner

reception

$ 250

DxPx Tickets for Industry Companies

 

DxPx is the prime location for industry leaders in Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools space come to technology scout and find the next big thing in the industry. All industry tickets include the following – 

  • 4 Days of in-person meetings – July 29th – August 1st, 2024
  • Access all exhibition, networking, Startup City areas & panel discussions
  • Partnering Platform to schedule in-person meetings

Industry Company Standard Ticket

benefits

$ 2,500 2,250

Industry Company - 42plus1 Online Juror Ticket

$ 0

DxPx Tickets for Investors

DxPx is proud to provide complimentary tickets to investors in the medtech and healthtech space. As part of your attendance at DxPx, you’ll also be able to participate as a judget in our 42plus1 pitch competition. All investor tickets include the following – 

  • 4 Days of in-person meetings – July 29th – August 1st, 2024
  • Access all exhibition, networking, Startup City areas & panel discussions
  • Partnering Platform to schedule in-person meetings

Investor Ticket

$ 0*

Investor Networking Dinner

reception

$ 250

Accelerators/Incubators

DxPx-Conference-375-Web-1

$ 1,299 1,049

Service Providers

$ 3,499*

Press

exhibition booth

$ 0*

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience